… specialty active pharmaceutical ingredients; and Pfizer Ignite, a recently launched offering … press release (available at www.pfizer.com ) for additional information. … . Talzenna (talazoparib) – In February 2023, Pfizer announced positive results from the …

… momentum. The results underscore Pfizer’s strategic pivot away … Cutting and Operational Efficiency Pfizer’s earnings were bolstered … from innovative therapies, but Pfizer’s raised ambitions suggest … Overall, while challenges persist, Pfizer’s Q2 results, as …

Pfizer’s 20-valent pneumococcal conjugate … care therapeutic area lead at Pfizer Korea. “With its inclusion in …

… U.S. pharmaceutical company Pfizer announced its second-quarter earnings … the second quarter," Pfizer Chairman and CEO Albert … 17 pharmaceutical companies, including Pfizer, demanding that they cut … quot;extremely productive." Pfizer's Q2 results …

… contracts with major players like Pfizer and Moderna, redirecting resources toward …

… questions posed to him during Pfizer’s second quarter earnings … peers at other companies that Pfizer will await the Section … discuss tariffs, he added. Pfizer’s latest guidance absorbs the … and drug pricing impact, Pfizer reaffirmed its revenue guidance of …

… Starboard. Bourla said: “Pfizer had another strong quarter of … group of drugs in Pfizer’s portfolio, representing the … for drug pricing changes – Pfizer was among the companies … generic and biosimilar competition. Pfizer lost patent protection for blockbuster …

Pfizer (PFE) CEO Albert Bourla said … is made," Bourla said. Pfizer is also one of the …